Physician profile
Benjamin I Shepple
NPI 1083848733
$2,509.87
in general payments reported to CMS, 2019-2025
22 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $122 · 2021: $49.83 · 2022: $465 · 2023: $379 · 2024: $653 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,574.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $732.70 | 2019-2025 | Cardiomems, Mitraclip, Optis |
| Novartis Pharmaceuticals Corporation | $457.37 | 2019-2025 | |
| Abiomed | $247.61 | 2020-2024 | Impella |
| Ge Healthcare | $131.85 | 2022 | |
| Cvrx, INC. | $118.54 | 2024 | Barostim Neo System |
| Pfizer INC. | $115.73 | 2020-2024 | |
| Inspire Medical Systems, INC. | $115.36 | 2024-2025 | Inspire |
| Lantheus Medical Imaging, INC. | $112.47 | 2019-2024 | |
| Heartflow, INC. | $85.77 | 2025 | |
| Edwards Lifesciences Corporation | $85.42 | 2025 | Pascal |
| Boston Scientific Corporation | $51.09 | 2020-2024 | |
| Atricure, INC. | $44.83 | 2023 | |
| Janssen Pharmaceuticals, INC | $35.85 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $32.06 | 2022-2024 | Eliquis |
| Amgen INC. | $31.75 | 2019-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $21.48 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $18.36 | 2023 | Amvuttra |
| Philips North America LLC | $17.72 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $15.34 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $14.36 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.33 | 2019 | |
| Cardinal Health 200 LLC | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Shepple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.